TY - CHAP
T1 - The TNF–TNFR family of co-signal molecules
AU - So, Takanori
AU - Ishii, Naoto
N1 - Funding Information:
Acknowledgments This work was supported by JSPS KAKENHI Grant Numbers 24590571 (to T.S.), 15H04640 (to T.S.), 18H02572 (to T.S.), 24390118 (to N.I.), 15H04742 (to N.I.), and 16K15508 (to N.I.), as well as by grants from the Takeda Science Foundation (to T.S.), the Suzuken Memorial Foundation (to T.S.), the SENSHIN Medical Research Foundation (to T.S.), the Astellas Foundation for Research on Metabolic Disorders (to T.S.), the Yamaguchi Educational and Scholarship Foundation (to T.S.), and the Daiichi-Sankyo Foundation of Life Science (to N.I. and T.S.).
Publisher Copyright:
© Springer Nature Singapore Pte Ltd 2019.
PY - 2019
Y1 - 2019
N2 - Costimulatory signals initiated by the interaction between the tumor necrosis factor (TNF) ligand and cognate TNF receptor (TNFR) superfamilies promote clonal expansion, differentiation, and survival of antigen-primed CD4+ and CD8+ T cells and have a pivotal role in T-cell-mediated adaptive immunity and diseases. Accumulating evidence in recent years indicates that costimulatory signals via the subset of the TNFR superfamily molecules, OX40 (TNFRSF4), 4-1BB (TNFRSF9), CD27, DR3 (TNFRSF25), CD30 (TNFRSF8), GITR (TNFRSF18), TNFR2 (TNFRSF1B), and HVEM (TNFRSF14), which are constitutive or inducible on T cells, play important roles in protective immunity, inflammatory and autoimmune diseases, and tumor immunotherapy. In this chapter, we will summarize the findings of recent studies on these TNFR family of co-signaling molecules regarding their function at various stages of the T-cell response in the context of infection, inflammation, and cancer. We will also discuss how these TNFR co-signals are critical for immune regulation and have therapeutic potential for the treatment of T-cell-mediated diseases.
AB - Costimulatory signals initiated by the interaction between the tumor necrosis factor (TNF) ligand and cognate TNF receptor (TNFR) superfamilies promote clonal expansion, differentiation, and survival of antigen-primed CD4+ and CD8+ T cells and have a pivotal role in T-cell-mediated adaptive immunity and diseases. Accumulating evidence in recent years indicates that costimulatory signals via the subset of the TNFR superfamily molecules, OX40 (TNFRSF4), 4-1BB (TNFRSF9), CD27, DR3 (TNFRSF25), CD30 (TNFRSF8), GITR (TNFRSF18), TNFR2 (TNFRSF1B), and HVEM (TNFRSF14), which are constitutive or inducible on T cells, play important roles in protective immunity, inflammatory and autoimmune diseases, and tumor immunotherapy. In this chapter, we will summarize the findings of recent studies on these TNFR family of co-signaling molecules regarding their function at various stages of the T-cell response in the context of infection, inflammation, and cancer. We will also discuss how these TNFR co-signals are critical for immune regulation and have therapeutic potential for the treatment of T-cell-mediated diseases.
KW - 4-1BB
KW - CD27
KW - CD30
KW - DR3
KW - GITR
KW - HVEM
KW - OX40
KW - TNFR2
KW - TNFRSF
KW - TNFSF
UR - http://www.scopus.com/inward/record.url?scp=85075440345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075440345&partnerID=8YFLogxK
U2 - 10.1007/978-981-32-9717-3_3
DO - 10.1007/978-981-32-9717-3_3
M3 - Chapter
C2 - 31758531
AN - SCOPUS:85075440345
T3 - Advances in Experimental Medicine and Biology
SP - 53
EP - 84
BT - Advances in Experimental Medicine and Biology
PB - Springer
ER -